ABCA1 Gene HDL Deficiency Type 2 Genetic Test
Test Details
The ABCA1 gene is responsible for encoding a protein called ATP-binding cassette transporter A1. This protein plays a crucial role in the transport of cholesterol and phospholipids from cells to high-density lipoprotein (HDL), commonly known as “good” cholesterol.
HDL deficiency type 2 refers to a condition where there is a mutation or dysfunction in the ABCA1 gene, leading to reduced or dysfunctional HDL production. This can result in low levels of HDL cholesterol in the blood, which is associated with an increased risk of cardiovascular diseases, such as atherosclerosis and coronary artery disease.
Next-generation sequencing (NGS) genetic testing is a method used to analyze multiple genes simultaneously and identify genetic variations or mutations that may be responsible for a particular condition or disease. In the case of ABCA1 gene HDL deficiency type 2, NGS genetic testing can help identify any genetic variants or mutations in the ABCA1 gene that may be contributing to the condition.
By identifying these genetic variations, healthcare professionals can better understand the underlying cause of the HDL deficiency and provide appropriate treatment and management strategies. Additionally, NGS genetic testing can also help identify individuals who may be at increased risk of developing cardiovascular diseases due to ABCA1 gene mutations, allowing for early intervention and preventive measures.
Test Name: ABCA1 Gene HDL Deficiency Type 2 Genetic Test
- Components: ABCA1 Gene HDL deficiency type 2 Genetic Test
- Price: 4400.0 AED
- Sample Condition: Blood
- Report Delivery: 3 to 4 Weeks
- Method: NGS Technology
- Test type: Metabolic Disorders
- Doctor: General Physician
- Test Department: Genetics
Pre Test Information
Clinical History of Patient who is going for ABCA1 Gene HDL deficiency, type 2 NGS Genetic DNA Test
A Genetic Counselling session to draw a pedigree chart of family members affected with HDL deficiency, type 2
| Test Name | ABCA1 Gene HDL deficiency type 2 Genetic Test |
|---|---|
| Components | |
| Price | 4400.0 AED |
| Sample Condition | Blood |
| Report Delivery | 3 to 4 Weeks |
| Method | NGS Technology |
| Test type | Metabolic Disorders |
| Doctor | General Physician |
| Test Department: | Genetics |
| Pre Test Information | Clinical History of Patient who is going for ABCA1 Gene HDL deficiency, type 2 NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with HDL deficiency, type 2 |
| Test Details |
The ABCA1 gene is responsible for encoding a protein called ATP-binding cassette transporter A1. This protein plays a crucial role in the transport of cholesterol and phospholipids from cells to high-density lipoprotein (HDL), commonly known as “good” cholesterol. HDL deficiency type 2 refers to a condition where there is a mutation or dysfunction in the ABCA1 gene, leading to reduced or dysfunctional HDL production. This can result in low levels of HDL cholesterol in the blood, which is associated with an increased risk of cardiovascular diseases, such as atherosclerosis and coronary artery disease. Next-generation sequencing (NGS) genetic testing is a method used to analyze multiple genes simultaneously and identify genetic variations or mutations that may be responsible for a particular condition or disease. In the case of ABCA1 gene HDL deficiency type 2, NGS genetic testing can help identify any genetic variants or mutations in the ABCA1 gene that may be contributing to the condition. By identifying these genetic variations, healthcare professionals can better understand the underlying cause of the HDL deficiency and provide appropriate treatment and management strategies. Additionally, NGS genetic testing can also help identify individuals who may be at increased risk of developing cardiovascular diseases due to ABCA1 gene mutations, allowing for early intervention and preventive measures. |
